Tatva Chintan closes trading window for Q1FY27 results
Tatva Chintan Pharma Chem Ltd has closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results declaration, complying with SEBI regulations to prevent insider trading.
*this image is generated using AI for illustrative purposes only.
Tatva Chintan Pharma Chem Ltd has closed its trading window for all designated persons and their immediate relatives, effective from July 1, 2026. The restriction will remain in place until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is implemented to prevent potential insider trading during the sensitive period preceding the financial announcement.
The closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code on prohibition of insider trading. All designated persons and their immediate relatives have been advised to refrain from dealing in the securities of the company during this period.
The unaudited financial results for the quarter ending June 30, 2026, are expected to be released shortly. The trading window will reopen 48 hours after the results are made public, allowing designated persons to resume trading activities.
| Key Details |
|---|
| Trading Window Closure Start Date |
| Trading Window Reopens |
| Quarter Ending |
| Regulation |
Historical Stock Returns for Tatva Chintan Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.95% | +1.37% | +5.68% | -6.33% | +25.98% | -47.89% |
How might the market react to the unaudited Q1FY27 results given the current trading restrictions?
What are the expected revenue and profit trends for Tatva Chintan in the upcoming fiscal year?
Could the closure of the trading window signal any significant strategic shifts or upcoming announcements?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
